The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats

Urological Research

Volumn 30, Issue 5, 2002, Pages 329-335

  Nakatani, Tatsuya ^a   Ishii, Keiichi ^b   Yoneda, Yukio ^a   Kamikawa, Sadanori ^b   Kanazawa, Toshinao ^a   Sugimoto, Toshikado ^b   Oßwald, Hartmut ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium oxalate; Hyperoxaluria; Macroautoradiography; Radioluminography; Rat; Sodium pentosan polysulfate

Indexed keywords

CALCIUM OXALATE; CARBON 14; OXALIC ACID; PENTOSAN POLYSULFATE; PYRIDOXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIET; DRUG MECHANISM; HYPEROXALURIA; MALE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; RAT; STONE FORMATION; TREATMENT OUTCOME;

ANIMALS; AUTORADIOGRAPHY; CALCIUM; CALCIUM OXALATE; HYPEROXALURIA; KIDNEY; KIDNEY CALCULI; KIDNEY MEDULLA; MALE; PENTOSAN SULFURIC POLYESTER; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 12244280784     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0271-4     Document Type: Article

References (21)

1. Amemiya Y, Miyahara J (1988) Imaging plate illuminates many fields. Nature 336: 89
2. Boevé ER, Cao LC, Verkoelen CF, Romijin JC, de Bruijn WC, Schröder FH (1994) Glycosaminoglycans and other sulphated polysaccharides in calculogenesis on urinary stones. World J Urol 12: 43
3. Chiang G, Patra P, Letouruneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC (2000) Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol 164: 2119
4. Dealler S (1998) Post-exposure polyphylaxis after accidental prion inoculation. Lancet 351: 600
5. Farquhar C, Dickinson A, Bruice M (1999) Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 353: 117
6. Fellström B, Backman U, Danielson B, Wikström B (1994) Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate. World J Urol 12: 52
7. Gershoff SN, Faragalla FF (1959) Endogenous oxalate synthesis and glycine, serine, deoxypyridoxine interrelationships in vitamin B6-deficient rats. J Biol Chem 234: 2391
8. Ishii K, Sugimoto T, Yoneda Y, Kamikawa S, Iimori H, Kanazawa T, Nakatani T, Yamamoto K, Funae Y, Oßwald H, Kishimoto T(1995) Microautoradiographic study on calcium oxalate crystal fixation in rat kidney by means of thaw mount method. Proceedings of the 6th European Symposium on Urolithiasis, Akademitryck AB, Stockholm, p 36
9. Kanazawa T, Sugimoto T, Kamikawa S, Iimori H, Yamamoto K, Nakatani T, Oßwald H, Funae Y, Kishimoto T (1994) Macro and micro autoradiographic studies on oxalate in normal and hyperoxaluric rats. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum, New York, p 113
10. Lyon ES, Borden TA, Vermeulen GW (1964) Experimental oxalate lithiasis produced with ethyleneglycol. Invest Urol 6: 143
11. Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E (2000) Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelbic pain syndrom category VA): a prospective multicenter clinical trial. Urology 56: 413
12. Norman RW, Scurr DS, Robertson WG, Peacock M (1984) Inhibition of calcium oxalate crystallization by pentosan polysulphate in control subjects and stone formers. Br J Urol 56: 594
13. Oßwald H, Weinheimer G, Shüdt ID, Erunst W (1989) Effective prevention of calcium oxalate crystal formation in vitro and in vivo by pentosan polysulfate. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum, New York, p 141
14. Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. Studies on their mode of action in an artificial urine. J Urol 136: 128
15. Senthil D, Subha K, Saravanan N, Varalakshmi P (1996) Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth. Mol Cell Biochem 156: 31
16. Senthil D, Malini MM, Varalakshmi P (1998) Sodium pentosan polysulphate-a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats. Ren Fail 20: 573
17. Subha K, Varalakshmi P (1993) Changes in renal tissue glycosaminoglycans in urolithiatic treated with sodium pentosan polysulphate. Med Sci Res 21: 233
18. Sugimoto T, Funae Y, Rübben H, Nishio S, Hautmann R, Lutzeyer W (1985) Resolution of proteins in the kidney stone matrix using high-performance liquid chromatography. Eur Urol 11: 334
19. Sugimoto T, Osswald H, Yamamoto K, Kanazawa T, Iimori H, Funae Y, Kamikawa S, Kishimoto T (1993) Fate of circulating oxalate in rats. Eur Urol 23: 485
20. Suzuki K, Tsugawa R (1995) Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine. Scan Micros 9: 1089
21. Tiselius H-G, Hallin A, Lindbäck B (2001) Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29: 75